Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Island Pharmaceuticals has received an $865,230 refund under Australia’s R&D Tax Incentive, which has allowed them to repay a loan from Radium Capital. This funding comes as the company advances its clinical programs, including the promising ISLA-101 nearing a Phase 2a data readout, and explores new assets like galidesivir.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Nvidia Stock Could Take a Beating from Supply Snags on Blackwell Chips
- ‘This Is Just Pure Hype,’ Says Top Investor About Tesla Stock
- Will Palantir Stock Crash to $28? Jefferies Sounds the Alarm
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
